| Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response Y Haberman, R Karns, PJ Dexheimer, M Schirmer, J Somekh, I Jurickova, ... Nature communications 10 (1), 38, 2019 | 309 | 2019 |
| Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study JS Hyams, SD Thomas, N Gotman, Y Haberman, R Karns, M Schirmer, ... The Lancet 393 (10182), 1708-1720, 2019 | 164 | 2019 |
| Blood-derived DNA methylation signatures of Crohn's disease and severity of intestinal inflammation HK Somineni, S Venkateswaran, V Kilaru, UM Marigorta, A Mo, DT Okou, ... Gastroenterology 156 (8), 2254-2265. e3, 2019 | 124 | 2019 |
| A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia TR Docking, JDK Parker, M Jädersten, G Duns, L Chang, J Jiang, ... Nature Communications 12 (1), 2474, 2021 | 87 | 2021 |
| Disease-specific regulation of gene expression in a comparative analysis of juvenile idiopathic arthritis and inflammatory bowel disease A Mo, UM Marigorta, D Arafat, LHK Chan, L Ponder, SR Jang, J Prince, ... Genome medicine 10, 1-16, 2018 | 56 | 2018 |
| Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del (5q) myelodysplastic syndrome S Martinez-Høyer, Y Deng, J Parker, J Jiang, A Mo, TR Docking, ... Nature cell biology 22 (5), 526-533, 2020 | 40 | 2020 |
| Clinical and host biological factors predict colectomy risk in children newly diagnosed with ulcerative colitis JS Hyams, M Brimacombe, Y Haberman, T Walters, G Gibson, A Mo, ... Inflammatory Bowel Diseases 28 (2), 151-160, 2022 | 22 | 2022 |
| Assessing cellular and transcriptional diversity of ileal mucosa among treatment-naïve and treated Crohn’s disease SC Maddipatla, VL Kolachala, S Venkateswaran, AF Dodd, RS Pelia, ... Inflammatory Bowel Diseases 29 (2), 274-285, 2023 | 17 | 2023 |
| African ancestry proportion influences ileal gene expression in inflammatory bowel disease A Mo, C Krishnakumar, D Arafat, T Dhere, H Iskandar, A Dodd, J Prince, ... Cellular and molecular gastroenterology and hepatology 10 (1), 203-205, 2020 | 14 | 2020 |
| Stratification of risk of progression to colectomy in ulcerative colitis via measured and predicted gene expression A Mo, S Nagpal, K Gettler, T Haritunians, M Giri, Y Haberman, R Karns, ... The American Journal of Human Genetics 108 (9), 1765-1779, 2021 | 11 | 2021 |
| A gene locus that controls expression of ACE2 in virus infection MA Ansari, E Marchi, N Ramamurthy, D Aschenbrenner, CP Hackstein, ... medRxiv, 2020.04. 26.20080408, 2020 | 11* | 2020 |
| Disease-specific regulation of gene expression in a comparative analysis of juvenile idiopathic arthritis and inflammatory bowel disease. Genome Med. 2018; 10 (1): 48 A Mo, UM Marigorta, D Arafat, LHK Chan, L Ponder, SR Jang, G Gibson | 9 | 2018 |
| Loss of FBXO11 functions drives acute myeloid leukemia A Mo, L Chang, G Duns, R Ibrahim, R Docking, P Umlandt, J Parker, ... Experimental Hematology 76, S78, 2019 | 4 | 2019 |
| Loss of FBXO11 function establishes a stem cell program in acute myeloid leukemia through dysregulation of the mitochondrial protease LONP1 A Mo, H Kincross, X Wang, LYT Chang, G Duns, H Kwan, T Lau, ... Blood 140 (Supplement 1), 8688-8689, 2022 | 2 | 2022 |
| Resistance to lenalidomide in del (5q) MDS is mediated by inhibition of drug-induced megakaryocytic differentiation S Martinez-Høyer, A Mo, D Deng, J Jiang, R Docking, J Li, S Chan, ... Blood 132 (Supplement 1), 176-176, 2018 | 2 | 2018 |
| Genomic and Transcriptomic Characterization of Inflammatory Bowel Disease A Mo Georgia Institute of Technology, 2021 | 1 | 2021 |
| Stratification of risk of progression to colectomy in ulcerative colitis using measured and predicted gene expression A Mo, S Nagpal, K Gettler, T Haritunians, M Giri, Y Haberman, R Karns, ... bioRxiv, 2021.04. 02.438187, 2021 | 1 | 2021 |
| In vivo negative regulation of SARS-CoV-2 receptor, ACE2, by interferons and its genetic control A Ansari, E Marchi, N Ramamurthy, D Aschenbrenner, S Morgan, ... Wellcome Open Research 6, 2021 | 1 | 2021 |
| Elucidating the Mechanisms of Leukemogenesis Driven By FBXO11 Depletion A Mo, LYT Chang, G Duns, X Wang, G Morin, T Lau, R Docking, ... Blood 138, 3328, 2021 | | 2021 |
| 3023–ELUCIDATING THE MECHANISMS OF LEUKEMOGENESIS DRIVEN BY FBXO11 LOSS A Mo, L Chang, G Duns, X Wang, R Docking, J Jiang, E Willie, S Huang, ... Experimental Hematology 100, S54, 2021 | | 2021 |
